Once-Weekly Tanzeum for Type 2s Now Available
Tanzeum (albiglutide), a once-weekly injectable drug for type 2s from GSK (GlaxoSmithKline), USA is now available at pharmacies throughout the
Read more
Bydureon
FDA Backtracks Over GLP-1s’ Effects on Pancreas
The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a
Read more
Weekly Type 2 Drug to Be Delivered Via Needle Patch
A recent agreement between Zosano Pharma, Inc. and Novo Nordisk could lead to the introduction of a once-weekly drug for
Read more
Am I Doing the Right Thing?
Readers occasionally ask us for advice about drugs they are taking. When they do, we refer their questions to a
Read more
An Update on Bydureon
Give us feedback about your experience with it
Read more
FDA Gives Long-Awaited Nod to Amylin’s Bydureon
After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The
Read more